Synthesis and Anticancer Activity of Homodimeric Morita-Baylis-Hillman Adducts Based on 3-Hydroxyindolin-2-one Core
作者:Maísa Coelho、Aleff Castro、Tayná Olegário、Rodrigo Cristiano、Boniek Vaz、Gabriel dos Santos、Lucas Machado、Gardênia Militão、Paulo da Silva、Mário Vasconcellos、Claudio Lima-Junior
DOI:10.21577/0103-5053.20230038
日期:——
extensive pharmacological profile. The use of 1,4-diazabicyclo[2,2,2]octane (DABCO) as a catalyst and room temperature were the optimal conditions for the study reaction. The isolated yields were up to 63%, with most reaction times inferior to 24 h, some as fast as 15 min. The anticancer potential of the synthesized dimers was evaluated in vitro against three cancer strains, resulting in average inhibitory
癌症治疗是当今科学研究的主要目标之一,这主要是因为化疗会产生明显的副作用。本研究报告了 Morita-Baylis-Hillman 反应产生的十种化合物的合成、表征和抗癌活性。在与异靛红衍生物的反应中,乙二醇二丙烯酸酯被用作双迈克尔受体,从而得到 3- 羟基吲哚啉-2-酮核心的同二聚体。使用 1,4-二氮杂双环[2,2,2]辛烷(DABCO)作为催化剂和室温是研究反应的最佳条件。分离出的产率高达 63%,大多数反应时间低于 24 小时,有的甚至快至 15 分钟。体外评估了合成二聚物对三种癌症菌株的抗癌潜力,结果显示平均抑制浓度高达 0.72 μM。研究还发现,表现最好的同源二聚体比单体的活性更高。考虑到观察到的良好选择性指数,本文获得的初步结果为更广泛地测试同源二聚体加合物对癌细胞的有效性奠定了基础。